These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12056717)

  • 1. Comment on "Perhaps not everyone knows that...", (Ann Oncol 2001; 12: 1186).
    Sulkes A; Schachter J
    Ann Oncol; 2002 Apr; 13(4):637. PubMed ID: 12056717
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ocular complications of adjuvant interferon therapy for malignant melanoma: a review].
    Ockenfels M; Lisch W
    Hautarzt; 2003 Feb; 54(2):144-7. PubMed ID: 12590309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant interferon for melanoma.
    Wheatley K; Ives N
    Ann Oncol; 2002 Aug; 13(8):1319-20; author reply 1320. PubMed ID: 12181258
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cutaneous necrosis due to interferon alpha in a patient with melanoma].
    Aguilar García G; Serrano Falcón C; Serrano Falcón Mdel M; Carmona MD; Linares Solano J; Serrano Ortega S
    Actas Dermosifiliogr; 2006 Oct; 97(8):539-42. PubMed ID: 17067536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [After removal of a malignant melanoma. Enhancing the immune system!].
    MMW Fortschr Med; 1999 Nov; 141(44):66. PubMed ID: 10912153
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant interferon in the treatment of melanoma.
    Kirkwood JM
    Br J Cancer; 2000 May; 82(10):1755-6. PubMed ID: 10817514
    [No Abstract]   [Full Text] [Related]  

  • 7. Impaired platelet aggregation in melanoma patients treated with interferon-alpha-2b adjuvant therapy.
    Gutman H; Schachter J; Stopel E; Gutman R; Lahav J
    Cancer; 2002 Feb; 94(3):780-5. PubMed ID: 11857313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon adjuvant therapy of melanoma.
    Kirkwood JM; Wazer D; Rosenstein M
    Cancer; 1997 May; 79(9):1843-6. PubMed ID: 9129006
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon-alpha induced Raynaud's syndrome.
    Kruit WH; Eggermont AM; Stoter G
    Ann Oncol; 2000 Nov; 11(11):1501-2. PubMed ID: 11142493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of cutaneous melanoma.
    Tsao H; Atkins MB; Sober AJ
    N Engl J Med; 2004 Sep; 351(10):998-1012. PubMed ID: 15342808
    [No Abstract]   [Full Text] [Related]  

  • 11. Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2b.
    Moschos SJ; Kirkwood JM; Konstantinopoulos PA
    J Clin Oncol; 2004 Jan; 22(1):11-4. PubMed ID: 14665613
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipoatrophy associated with interferon alfa adjuvant therapy for melanoma.
    Vallés L; González M; Polo I; Enguita AB; Vanaclocha F; Ortiz-Romero PL
    Arch Dermatol; 2009 Jan; 145(1):98-9. PubMed ID: 19153363
    [No Abstract]   [Full Text] [Related]  

  • 13. [Feasability and tolerance of adjuvant treatment of melanoma with immunotherapy according to Kirkwood protocol].
    Uwer L; Martin S; Geoffrois L; Schmutz JL
    Ann Dermatol Venereol; 2005 Jan; 132(1):50-1. PubMed ID: 15746611
    [No Abstract]   [Full Text] [Related]  

  • 14. Grand mal seizure induced by interferon-alpha-2b.
    Kors C; Milling A; Hofmann M; Sterry W; Trefzer U
    J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):473-4. PubMed ID: 16643159
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of adjuvant interferon in high risk melanoma patients.
    Dermatol Surg; 2000 Jun; 26(6):607-8. PubMed ID: 10848951
    [No Abstract]   [Full Text] [Related]  

  • 16. Node positive melanoma--a positive note?
    Kelly J; Kerin MJ
    Surgeon; 2012 Apr; 10(2):63-4. PubMed ID: 22385525
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vitiligo and morphea: autoimmune cutaneous side effects of interferon treatment].
    Martínez-García S; Fernández-Ballesteros MD; Segura-Palacios JM
    Actas Dermosifiliogr; 2012 Apr; 103(3):250-1. PubMed ID: 22056259
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
    Schuchter LM
    J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe action tremor related to interferon-alpha 2b therapy for malignant melanoma.
    Nishihori T; Abdo-Matkiwsky M; Fleishman SB; Blum RH
    Am J Clin Oncol; 2005 Oct; 28(5):526. PubMed ID: 16199995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Livedo reticularis associated with interferon alpha therapy in two melanoma patients.
    Ruiz-Genao DP; García-F-Villalta MJ; Hernández-Núñez A; Ríos-Buceta L; Fernández-Herrera J; García-Díez A
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):252-4. PubMed ID: 15752306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.